Results of several studies performed over the past decade
have led to widespread adoption of cardiac resynchronization
therapy for treatment of patients with advanced heart
failure with dyssynchronous myocardial contraction indexed
by a prolonged QRS duration.1–5 However, it is
estimated that less than half of patients with advanced heart
failure have a prolonged QRS duration and therefore currently
are indicated for treatment with cardiac resynchronization
therapy.